TY  - GEN
AU  - Calleja,Jose L
AU  - Pascasio,Juan M
AU  - Ruiz-Antorán,Belén
AU  - Gea,Francisco
AU  - Bárcena,Rafael
AU  - Larrubia,Juan R
AU  - Pérez-Álvarez,Ramón
AU  - Sousa,Jose M
AU  - Romero-Gómez,Manuel
AU  - Solá,Ricard
AU  - de la Revilla,Juan
AU  - Crespo,Javier
AU  - Navarro,Jose M
AU  - Arenas,Juan I
AU  - Delgado,Manuel
AU  - Fernández-Rodríguez,Conrado M
AU  - Planas,Ramon
AU  - Buti,Maria
AU  - Forns,Xavier
TI  - Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis
SN  - 1478-3231
PY  - 2015///0928
KW  - Compassionate Use Trials
KW  - Drug Therapy, Combination
KW  - adverse effects
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C
KW  - complications
KW  - Humans
KW  - Interferon-alpha
KW  - Liver Cirrhosis
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - Proline
KW  - Prospective Studies
KW  - Protease Inhibitors
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Spain
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study
UR  - https://doi.org/10.1111/liv.12656
ER  -